Ishikawa J - Search Results

1

A treatment strategy to mitigate the adverse effect of pretransplant mogamulizumab on post-transplant clinical outcome in patients with aggressive ATL.

Fuji S, Yuda S, Tada Y, Kano M, Sanda K, Fujishita K, Terakawa T, Shingai Y, Kasahara H, Yokota T, Ishikawa J. Fuji S, et al. Among authors: ishikawa j. Br J Haematol. 2024 Feb;204(2):e25-e27. doi: 10.1111/bjh.19231. Epub 2023 Dec 6. Br J Haematol. 2024. PMID: 38053439 No abstract available.

2

A case of severe oral mucosal GVHD induced by heterologous SARS-CoV-2 vaccination after cord blood transplantation.

Sanda K, Fuji S, Satomi H, Kitamura M, Nishimura N, Tada Y, Shingai Y, Yuda S, Yokota T, Ishikawa J. Sanda K, et al. Among authors: ishikawa j. Blood Cell Ther. 2023 Apr 28;6(2):49-53. doi: 10.31547/bct-2022-019. eCollection 2023 May 25. Blood Cell Ther. 2023. PMID: 37342356 Free PMC article.

3

Successful treatment strategy in corporating mogamulizumab and cord blood transplantation in aggressive adult T-cell leukemia-lymphoma: a case report.

Nakata K, Fuji S, Koike M, Tada Y, Masaie H, Yoshida H, Watanabe E, Kobayashi S, Tojo A, Uchimaru K, Ishikawa J. Nakata K, et al. Among authors: ishikawa j. Blood Cell Ther. 2020 Feb 25;3(1):6-10. doi: 10.31547/bct-2019-012. eCollection 2020 Feb 25. Blood Cell Ther. 2020. PMID: 37465376 Free PMC article.

4

Impact of GVHD on lymphoma progression: Nationwide study from Japanese Society for Transplantation and Cellular Therapy.

Watanabe M, Kanda J, Fukuda T, Uchida N, Ikegame K, Kataoka K, Kobayashi H, Ara T, Ishikawa J, Matsuoka KI, Sugio Y, Nakazawa H, Ikeda T, Atsuta Y, Kondo E, Suzuki R; Japanese Society for Transplantation and Cellular Therapy, Adult Lymphoma Working Group. Watanabe M, et al. Among authors: ishikawa j. Br J Haematol. 2023 Nov;203(3):446-459. doi: 10.1111/bjh.19041. Epub 2023 Aug 23. Br J Haematol. 2023. PMID: 37614023

5

Relationship between muscle thickness measured by ultrasound and physical functions: A 2-year follow-up study of allogeneic hematopoietic stem cell transplantation recipients.

Ito K, Tada Y, Suzuki M, Hashida N, Kato Y, Yokota T, Ishikawa J, Tamiya H. Ito K, et al. Among authors: ishikawa j. PM R. 2024 Jun;16(6):570-585. doi: 10.1002/pmrj.13083. Epub 2024 Feb 1. PM R. 2024. PMID: 37844015

6

A single-institution pre-post comparison of subcutaneous immunoglobulin replacement therapy in allogeneic haematopoietic cell transplantation recipients.

Suga M, Fuji S, Tada Y, Tsutsumi K, Kida S, Shibata K, Nakata R, Shingai Y, Yuda S, Yokota T, Ishikawa J. Suga M, et al. Among authors: ishikawa j. Br J Haematol. 2024 Jan;204(1):260-267. doi: 10.1111/bjh.19203. Epub 2023 Nov 14. Br J Haematol. 2024. PMID: 37963427

7

Low- versus standard-dose post-transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation.

Fuji S, Sugita J, Najima Y, Konishi T, Tanaka T, Ohigashi H, Eto T, Nagafuji K, Hiramoto N, Matsuoka KI, Maruyama Y, Ota S, Ishikawa J, Kawakita T, Akasaka T, Kamimura T, Hino M, Fukuda T, Atsuta Y, Yakushijin K. Fuji S, et al. Among authors: ishikawa j. Br J Haematol. 2024 Mar;204(3):959-966. doi: 10.1111/bjh.19228. Epub 2023 Nov 30. Br J Haematol. 2024. PMID: 38037468

8

Gilteritinib in peritransplant period for relapsed or refractory FLT3-mutated acute myeloid leukemia: A case report of three patients.

Mima F, Fuji S, Shibata K, Kida S, Tsutsumi K, Tada Y, Shingai Y, Yuda S, Yokota T, Ishikawa J. Mima F, et al. Among authors: ishikawa j. Blood Cell Ther. 2023 Jun 9;6(3):77-79. doi: 10.31547/bct-2023-003. eCollection 2023 Aug 25. Blood Cell Ther. 2023. PMID: 38146352 Free PMC article.

9

Differentiating Between Epstein-Barr Virus-positive Lymphoid Neoplasm Relapse and Post-transplant Lymphoproliferative Disorder After Sex-mismatched Hematopoietic Stem Cell Transplantation.

Kurashige R, Kurashige M, Okada Y, Higuchi K, Yuda S, Hino A, Miyamura T, Ichii M, Fukushima K, Honma K, Takeuchi M, Yokota T, Ishikawa J, Sawada A, Shibayama H, Hosen N, Morii E. Kurashige R, et al. Among authors: ishikawa j. Am J Surg Pathol. 2024 Apr 1;48(4):395-405. doi: 10.1097/PAS.0000000000002183. Epub 2024 Jan 30. Am J Surg Pathol. 2024. PMID: 38287877

10

Association between human herpesvirus-6 encephalitis and antiviral prophylaxis after allogeneic hematopoietic stem cell transplantation in the letermovir era.

Terao T, Matsuoka KI, Fuji S, Kawamura S, Toya T, Doki N, Uchida N, Tanaka M, Fukuda T, Sawa M, Ishikawa J, Nishida T, Ohigashi H, Maruyama Y, Fujiwara SI, Kanda Y, Ota S, Ishimaru F, Atsuta Y, Kanda J, Ogata M, Yakushijin K, Nakasone H. Terao T, et al. Among authors: ishikawa j. Bone Marrow Transplant. 2024 Sep;59(9):1224-1231. doi: 10.1038/s41409-024-02313-3. Epub 2024 May 25. Bone Marrow Transplant. 2024. PMID: 38796633

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

746 results

Search Page

Filters